Prawo i regulacje · 05/08/2015
Patheon Pharmaceuticals, Inc. Receives DEA Registration for Controlled Substance Manufacturing
The Drug Enforcement Administration (DEA) has granted Patheon Pharmaceuticals, Inc. registration as a manufacturer of a specific class of controlled substances, following its application.
Original source language: Federal Register — Justice DepartmentOpen original release →